[go: up one dir, main page]

ES2182342T3 - Procedimiento para producir derivados de indol. - Google Patents

Procedimiento para producir derivados de indol.

Info

Publication number
ES2182342T3
ES2182342T3 ES98933651T ES98933651T ES2182342T3 ES 2182342 T3 ES2182342 T3 ES 2182342T3 ES 98933651 T ES98933651 T ES 98933651T ES 98933651 T ES98933651 T ES 98933651T ES 2182342 T3 ES2182342 T3 ES 2182342T3
Authority
ES
Spain
Prior art keywords
formula
indol
procedure
compounds
produce derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98933651T
Other languages
English (en)
Inventor
David Charles Waite
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2182342T3 publication Critical patent/ES2182342T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se refiere a un procedimiento para la producción de compuestos de fórmula (I) que comprende hacer reaccionar un compuesto de fórmula (II) con un compuesto de fórmula (III) en presencia de una base fuerte y un catalizador de paladio (0) y a una elevada temperatura y en un disolvente que no afecta negativamente a la reacción. Los compuestos de fórmula (I) se pueden procesar posteriormente hasta compuestos de fórmula (V) que son útiles en el tratamiento de, entre otros, migraña.
ES98933651T 1997-07-08 1998-06-16 Procedimiento para producir derivados de indol. Expired - Lifetime ES2182342T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714383.8A GB9714383D0 (en) 1997-07-08 1997-07-08 Improved process

Publications (1)

Publication Number Publication Date
ES2182342T3 true ES2182342T3 (es) 2003-03-01

Family

ID=10815557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98933651T Expired - Lifetime ES2182342T3 (es) 1997-07-08 1998-06-16 Procedimiento para producir derivados de indol.

Country Status (15)

Country Link
US (1) US6281357B1 (es)
EP (1) EP0975594B1 (es)
AR (1) AR013183A1 (es)
AT (1) ATE224367T1 (es)
AU (1) AU8339798A (es)
CA (1) CA2286720A1 (es)
DE (1) DE69808068T2 (es)
DK (1) DK0975594T3 (es)
ES (1) ES2182342T3 (es)
GB (1) GB9714383D0 (es)
IL (1) IL132442A0 (es)
PL (1) PL337000A1 (es)
PT (1) PT975594E (es)
WO (1) WO1999002493A1 (es)
ZA (1) ZA985918B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
WO2004056769A2 (en) * 2002-12-20 2004-07-08 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
US20100022581A1 (en) * 2008-07-02 2010-01-28 Memory Pharmaceuticals Corporation Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
CN102775342A (zh) * 2011-05-12 2012-11-14 上海医药工业研究院 一种抗偏头痛药物阿莫曲坦的制备方法
LT3448859T (lt) 2017-03-20 2019-10-25 Forma Therapeutics Inc Pirolpirolo kompozicijos, kaip piruvato kinazės (pkr) aktyvatoriai
US12053458B2 (en) 2018-09-19 2024-08-06 Novo Nordisk Health Care Ag Treating sickle cell disease with a pyruvate kinase R activating compound
US11001588B2 (en) 2018-09-19 2021-05-11 Forma Therapeutics, Inc. Activating pyruvate kinase R and mutants thereof
CN110483341A (zh) * 2019-07-23 2019-11-22 上海药明康德新药开发有限公司 一种1-氰基-n-甲基甲磺酰胺的合成方法
AU2020349555A1 (en) 2019-09-19 2022-04-07 Forma Therapeutics, Inc. Activating Pyruvate Kinase R
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DK0592438T5 (da) * 1990-10-15 1999-12-06 Pfizer Inc. Indolderivater
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines

Also Published As

Publication number Publication date
DE69808068T2 (de) 2003-02-06
CA2286720A1 (en) 1999-01-21
ZA985918B (en) 2000-01-10
EP0975594A1 (en) 2000-02-02
IL132442A0 (en) 2001-03-19
DE69808068D1 (de) 2002-10-24
US6281357B1 (en) 2001-08-28
AR013183A1 (es) 2000-12-13
DK0975594T3 (da) 2002-10-14
PL337000A1 (en) 2000-07-31
AU8339798A (en) 1999-02-08
PT975594E (pt) 2002-12-31
ATE224367T1 (de) 2002-10-15
EP0975594B1 (en) 2002-09-18
WO1999002493A1 (en) 1999-01-21
GB9714383D0 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
ES2182342T3 (es) Procedimiento para producir derivados de indol.
HRP990167B1 (en) Sulphinic acid derivatives, method for producing them, and their use
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
ES2123149T3 (es) Derivados de perhidroisoindol como antagonistas de la substancia p.
ES2176272T3 (es) Compuestos que contienen organopolisiloxanos con base acuosa, procedimiento para su produccion asi como su uso.
GB9822473D0 (en) Chemical compounds
HUT54119A (en) Process for producing antiinflammatory aminophenol derivatives
AR007280A1 (es) Derivados de sustancia activa, composicion y procedimiento para el tratamiento del cabello
AR034699A1 (es) Procedimiento para la preparacion de moduladores del receptor glucocorticoide no esteroideos y compuestos intermediarios
CA2325919A1 (en) Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
ES2140778T3 (es) Procedimiento para la preparacion de compuestos de 2-cianoimidazol 1-sustituidos.
AR027607A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica
ES8606321A1 (es) Un procedimiento para preparar un derivado de 2-hidroxi-3- (4-fenilpiperazimil)propoxi-benzofurano
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
MX171265B (es) Procedimiento para la oxidacion catalitica de alcanos en mezclas de alcoholes y cetonas
ES2063480T3 (es) Procedimiento para la obtencion de tioderivados de alquilhidroxianilino-triazina.
TR200002755T2 (tr) Aracı hazırlamak için süreç.
GB0109093D0 (en) Process for producing photocleavable compounds
MX3341E (es) Procedimiento para la preparacion de epoxi-androstanos
AR003328A1 (es) Proceso para la preparacion de nitro-sustituido-difenileteres, utiles como herbicidas o como intermediarios en la sintesis de herbicidas
NO991961D0 (no) FremgangsmÕte for Õ regenerere antrakinonderivater under hydrogenperoksyd-synteseprosessen
AR021005A1 (es) Procedimiento para la preparacion de cetiminas
BR0016204A (pt) Composição
ES2153789A1 (es) Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
ES2121293T3 (es) Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.